HSBC/CALL/PFIZER INC/65/0.1/15.01.25 Share Price

Warrant

DE000HG2DKY3

Market Closed - BOERSE MUENCHEN 01:06:46 31/05/2024 am IST
0.011 EUR 0.00% Intraday chart for HSBC/CALL/PFIZER INC/65/0.1/15.01.25
Date Price Change
30/24/30 0.011 0.00%
29/24/29 0.011 0.00%
28/24/28 0.011 0.00%
27/24/27 0.011 0.00%
24/24/24 0.011 0.00%

Real-time BOERSE MUENCHEN

Last update May 31, 2024 at 01:06 am IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
Issuer HSBC
WKN HG2DKY
ISINDE000HG2DKY3
Date issued 23/03/2022
Strike 65 $
Maturity 15/01/2025 (230 Days)
Parity 10 : 1
Emission price 0.74
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 0.73
Lowest since issue 0.011
Delta0.02x
Omega 8.183
Premium132.62x
Gearing430.06x
Moneyness 0.4303
Difference Strike 36.8 $
Difference Strike %+56.62%
Spread 0.01
Spread %90.91%
Theoretical value 0.006000
Implied Volatility 46.41 %
Total Loss Probability 99.26 %
Intrinsic value 0.000000
Present value 0.006000
Break even 65.06 €
Theta-0x
Vega0x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.82 USD
Average target price
31.92 USD
Spread / Average Target
+14.72%
Consensus